Investorideas.com newswire, breaking news for marijuana, cannabis and hemp stocks

Wednesday 24 March 2021

Breaking #FunctionalMushroom stock news - Link Reservations Inc/LinkResPet (OTC: $LRSV) - Preparing to Launch Immunity Boosting Functional Mushroom Product, @res_pet

 


Breaking #FunctionalMushroom stock news - Link Reservations Inc/LinkResPet (OTC: $LRSV) - Preparing to Launch Immunity Boosting Functional Mushroom Product, @res_pet

 

London, UK  March 24, 2021– Breaking Health and Wellness functional mushroom stock news from Investorideas.com Newswire - Link Reservations Inc. (OTC: LRSV), a provider of wellness and cannabidiol (CBD) products for both humans and pets, announces the company is preparing to launch its first functional mushroom product, DailyLife CBD Immune. The new tincture product, tailored for people, will feature both CBD and a wide spectrum of functional mushrooms (including Lion's Mane) which help boost the immune system.

 

Read this news, featuring LRSV in full at https://www.investorideas.com/news/2021/lohas/03242LRSV-Functional-Mushroom-Product.asp

 

"This is an exciting first step for the Company and we are thrilled to soon bring to market our first CBD mushroom product. Our focus has always been on providing high quality products that can help people benefit from the power of natural ingredients, and that is what we have aimed for with this product," commented Rene Lauritsen, Link Reservations Inc CEO. "Understandably, people are focusing on their health now more than ever and looking for ways in which they can boost their immunity, particularly in a natural way. Our goal is to fully satisfy their need with this new product. We have been researching the benefits of functional mushrooms for the past few months and have developed a product that will harness their power," added Lauritsen.

 

As the world continues to reel from the Coronavirus pandemic, and learns to live with the virus, many people are focusing on different ways to boost their immune system. According to Rick Miller, Associate Director of Food & Drink Specialised Nutrition at Mintel, the majority of consumers in Europe purchase vitamins, minerals and supplements that strengthen the immune system, while in the US, 35% of consumers think products that support the immune health would motivate them when making a purchase.

 

DailyLife CBD Immune will feature an organic blend of 13 different medicinal mushrooms, including Lion's Mane, Turkey Tail, Chaga, Red Reishi and Cordyceps, amongst others. By focusing on a variety of mushrooms the product is able to encompass multiple immune boosting traits and benefits. In addition, DailyLife CBD Immune also includes 250mg of hemp oil CBD extract and 100mg of vitamin C, which will add to the immune boosting benefits.

 

"We are confident that this product and our future ones will have a very warm reception in the market, and we look forward to sharing more developments as they arise through press releases," ended Lauritsen.

 

For more information about DailyLifeCBD please visit: https://dailylifecbd.com/

 

DailyLifeCBD is sister brand to LinkResPet, a website focused on providing CBD pet products for dogs, cats and horses. For more information about LinkResPet, please visit www.linkrespet.com or follow them on Twitter on @res_pet.

 

About Link Reservations Inc.

Link Reservations Inc is a CBD and wellness product provider dedicated to improving the health and life conditions of both people and pets worldwide. Its trades through its two brands; LinkResPet and DailyLifeCBD. LinkResPet develops and markets hemp-based CBD products for cats, dogs and horses. DailyLifeCBD provides everyday hemp-based CBD wellness products for people. The Company has operations in both the US and Europe.

 

Forward-Looking Statements & Disclaimers:

The information in this Press Release includes certain "forward-looking" statements within the meaning of the Safe Harbor provisions of Federal Securities Laws, as that term is defined in section 27a of the United States Securities Act of 1933, as amended, and section 21e of the United States Securities Exchange Act of 1934, as amended. Statements in this document, which are not purely historical, are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Investors are cautioned that such statements are based upon assumptions that in the future may prove not to have been accurate and are subject to significant risks and uncertainties, including the future financial performance of the Company. Although the Company believes that the expectations reflected in its forward-looking statements are reasonable, it can give no assurance that such expectations or any of its forward-looking statements will prove to be correct. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date of this release, and the Company undertakes no obligation to update publicly any forward-looking statements to reflect new information, events, or circumstances after the date of this release except as required by law.

 

Link Reservations Inc:
400 Thames Valley Park Drive
Reading Berkshire RG6 1 PT
United Kingdom
Phone: +44 330 808 0897

 

Paid News -Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure : this news release featuring LRSV is a paid for news release on Investorideas.com  More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

About Investorideas.com

https://www.investorideas.com/About/

 

Sign up for free stock news alerts at Investorideas.com

https://www.investorideas.com/Resources/Newsletter.asp

 

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others. 

 



Health, Wellness and Sustainability Stocks Research and News at Investorideas.com - investing ideas for a better world

Like Health, Wellness and Sustainability Stocks? View our LOHAS Stocks Directory

 



Get more Cannabis Stock Investor Ideas - news, articles, podcasts and stock directories

 

Tuesday 23 March 2021

Investor Ideas #Potcasts 544, #Cannabis News and #Stocks on the Move; (NASDAQ: $NEPT) (TSX: $NEPT.TO), (CSE: $CURA.C) (OTCQX: $CURLF), (OTC: $MJNA), (CSE: $OPTI.C) (CSE: $SILO.C)

 



 

Investor Ideas #Potcasts 544, #Cannabis News and #Stocks on the Move; (NASDAQ: $NEPT) (TSX: $NEPT.TO), (CSE: $CURA.C) (OTCQX: $CURLF), (OTC: $MJNA), (CSE: $OPTI.C) (CSE: $SILO.C)

 

 

Delta, Kelowna, BC, March 23, 2021 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

 

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2021/032321-StocksToWatch.mp3

 

Read this in full at https://www.investorideas.com/news/2021/cannabis-potcasts/03231NEPT-CURA-MJNA-OPTI-SILO.asp

 

Hear the investor ideas potcast on Spotify

 

Hear Investor ideas cannabis potcast on iTunes  

 

Today’s podcast overview/transcript:

 

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

 

In today’s podcast we look at a few public company announcements.

 

Neptune Wellness Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT), a diversified and fully integrated health and wellness company focused on natural, plant-based, sustainable and purpose-driven lifestyle brands, today announced that Health Canada has provided the Company with a license amendment to allow it to sell dried cannabis flower and pre-rolled cannabis in the Canadian recreational market.

 

Neptune currently supplies the market with premium cannabis extracts, under its Mood Ring™ and PanHash™ brands, and will expand its offering to include all regulated product categories. This empowers the Company to provide a comprehensive portfolio, enhance its total addressable market and target the lucrative flower segment, which is a dominant force in the industry both in sales and revenue.

 

"Dried flower and associated products derived therefrom will be the latest additions to Neptune's collection of cannabis products, which includes High CBD Oil, High CBD Oil Capsules and Legacy Hashish," said Neptune Wellness Solutions' President and Chief Executive Officer Michael Cammarata.

 

The license amendment enables Neptune to leverage trusted partnerships across its supply chain to acquire unique and highly sought-after cultivars. The Company's dried flower will be carefully selected and curated by an award-winning cannabis sommelier, and then hand packaged in premium packaging. This ensures that the integrity and quality of the carefully sourced flower will be maintained and preserved to provide supreme quality for the customer. The ability to source exceptional flower from any licensed producer will afford flexibility to maximize emerging commercial opportunities and will safeguard Neptune from increased industry volatility.

 

"This is a very exciting time for Neptune, allowing us to sell all categories of recreational cannabis to meet the demands of our Canadian consumers," said Mr. Cammarata. "We are excited to bring to market premium dried cannabis flower products that are packaged to preserve their quality and profile."

 

Today's announcement follows Neptune Wellness Solutions Inc. entering into a letter of intent with Société québécoise du cannabis (SQDC), the province's sole legal retailer for recreational cannabis, for the sale of Neptune's new cannabis brand, PanHash™.

As Neptune continues to redefine the recreational cannabis market, the Company has pledged to align with cultivators that share its core values of sustainability, accountability and excellence to furnish the industry with superior cannabis flower. All cannabis products are manufactured and packaged at the Company's purpose-built facility in Sherbrooke, Quebec.

 

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF), a leading U.S. provider of consumer products in cannabis, today launched Select Squeeze, a fast-acting THC-infused beverage enhancer featuring Nano-emulsification technology. In addition to the product's innovative nature, the debut of Select Squeeze marks a significant milestone as one of the cannabis industry's widest national product launches. Select Squeeze is among the first cannabis products with mass availability as it becomes accessible to a total addressable population of 94 million adults age 21+.

 

Select, known as America's #1 Cannabis Oil Brand, has a variety of best-in-class cannabis products in over 1500 locations across 18 states. The curation of those products is unique to each market, reflecting the various regulations at a local level. Continuing on its path to becoming the first nationally recognized cannabis brand, Select is determined to provide patients and customers with consistent access to the products they know and trust. Starting this week, Select Squeeze is launching simultaneously across nine states including Arizona, Colorado, Connecticut, Massachusetts, Maine, Oklahoma, Oregon, Utah and Vermont. In April, Select Squeeze will launch in an additional five states including California, Florida, Illinois, Nevada and Ohio.

 

Select Squeeze is an advanced formulation that utilizes Nanotechnology to transform any beverage into a THC-infused, flavor-enhanced experience. By turning cannabis oil into tiny water-soluble molecules, the THC compounds not only dissolve evenly into any beverage but are also more rapidly and efficiently absorbed into the bloodstream, with effects felt in as little as 15-30 minutes, significantly faster than traditional edibles. The product's intuitive, proprietary bottle design features a unique fill-and-pour reservoir that makes precision dosing more straightforward than ever. The compact design also makes it ideal for discreet enjoyment on the go. Select Squeeze will launch with four flavor varieties, including Lemon-Lime, Watermelon, Strawberry Lemonade, and Hint of Sweet, allowing effective flavor pairings with a wide range of beverages, hot or cold.

 

"Curaleaf has been on the forefront of creating sophisticated cannabis experiences and introducing high-quality, consistent consumer products in a variety of form functions," said Joe Bayern, CEO of Curaleaf. "We're incredibly excited to launch Select Squeeze across multiple states, as this new product not only addresses the rising market demand for edibles and beverage products but also underscores the mainstream adoption of cannabis products across a diverse array of U.S. consumers."

 

With the launch of Select Squeeze today, Select products are currently available in 18 states, including Arizona, California, Colorado, Connecticut, Florida, Illinois, Maine, Massachusetts, Michigan, Maryland, New York, Nevada, Ohio, Oklahoma, Oregon, Pennsylvania, Utah, and Vermont. Squeeze will sit alongside a full lineup of Select vape products (Elite, Elite Live, Fresh and Essentials), as well as edibles and sublingual products, which include Select's Classic Gummies, Nano Gummies, and Ratio Drops. To find out more about Select's portfolio of products or find a dispensary near you that carries Select products, go to www.selectbetter.com.

 

Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, reports today that its subsidiary Kannaway® participated in, and today announces the recent positive results, of the Validcare clinical study. The study used Kannaway®’s hemp-derived cannabidiol (CBD) products as a part of its efforts to meet the Food and Drug Administration (FDA)’s request for data on the use of botanical CBD with regard to potential liver toxicity issues, which seem to occur with the pharmaceutical version of CBD.

 

According to Validcare’s team of principal investigators, the study showed no evidence of liver toxicity in the 839 trial participants who ingested oral forms of hemp-derived CBD for a minimum of 60 days. The investigators met with the Food and Drug Administration (FDA) Cannabis Product Council (formerly known as the Cannabis Work Group) on Monday, March 15, to share these findings and answer the organization’s March 5, 2020, request for science-based data to help determine the appropriate regulatory path for hemp-derived CBD products. Blood markers for ALT (Alanine Aminotransferase), AST (Aspartate Aminotransferase), ALP (Alkaline Phosphatase), and Bilirubin levels were examined during the study.

 

“These study results help support the work that we’ve been doing in Mexico and Brazil to study CBD’s safety and efficacy,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “We hope to continue to participate in similar future studies so that the world can continue to have expanded access to high-quality botanical products. I am glad to see participating stakeholders with longer-term visions banding together to make industry-wide progress that ultimately will benefit end consumers. Our company is involved with similar research in Europe in conjunction with the European Industrial Hemp Association (EIHA).”

 

Brands that participated in this study provided funding, product, certificates of authenticity, and assisted with the recruitment of adult US-based consumers. The use of Validcare’s decentralized clinical research platform and partnership with national laboratories enabled participants and principal investigators to successfully complete this first cohort, despite the pandemic, and compile and deliver results to brands and the FDA within six weeks.

 

“As the creators of some of the first testing measures for the entire CBD industry, many that are still used by other companies today, we are proud to be a part of this study and continue to be leaders in CBD safety testing,” said Kannaway® CEO Blake Schroeder. “Providing the highest-quality, safest products on the market is something we are proud of.”

 

Optimi Health Corp. (CSE: OPTI), developers of a vertically integrated functional mushroom brand focused on the health and wellness sector, provided the following overview and update of its facility construction and Controlled Substance Dealer Licensing activities to-date.

 

Optimi began construction of its two adjacent 10,000 square foot facilities in Princeton, British Columbia in August of 2020. Phase One included all civil engineering including perimeter controls, foundations, building exteriors, water and sewerage connections, interior drainage, and flooring, which have been completed and approved. (See Figure 1)

 

The second phase which commenced in January 2021, involves a comprehensive pharmaceutical grade interior buildout of the functional mushroom cultivation and processing facility including state-of-the-art machinery and processing equipment as well as an advanced analytics laboratory, and is expected to reach completion this summer with final preparations to commence planting in Q3, 2021 with a subsequently anticipated 50-day timeline to inaugural harvest. The environmental design employs highly efficient clean room technology throughout the facility. The Optimi team brings previous successful experience with similar technology which is being leveraged to make an application for valuable power consumption energy grants offering significant cost advantages on an annualized basis.

 

As a result of unusually mild winter conditions, and rapid adoption of pandemic health and safety measures, the Optimi team is pleased to report that Phase One completed ahead of schedule and below the projected cost estimate, with the entire project currently within the originally proposed $8.2 million budget.

 

It is anticipated that April will bring a stage-3 security inspection under the auspices of the Office of Controlled Substances (OCS) which manages applications for Controlled Drugs and Substances Dealer's Licences submitted in accordance with the Controlled Drugs and Substances Act (CDSA). The Company has completed the application intake and review phase and is confident the facility meets or exceeds the legally required security obligations. The inspection should lead to a timely decision to grant a Dealer’s License thereby enabling the Company to commence production and research into psilocybin-derived psychedelic compounds, concurrent with its functional mushroom commercial retail operations.

 

Optimi Health COO and Director, Bryan Safarik, comments, “Our efforts in Princeton are moving ahead rapidly and every day brings us ever closer to our goals. We’re ahead of schedule, under budget, and perhaps most importantly, the civic leadership have been extraordinarily supportive. I want to personally thank Mayor Spencer Coyne and economic development director Gray Schatz for their ongoing commitment and support. Interest in what we are doing has seen us receive many excellent resumes with strong science backgrounds. We have been approached by numerous professors and researchers across North America reaching out to work with Optimi as interest in the mushroom sector continues to grow. The year ahead is looking even more promising than I had envisioned when we began, and the entire team is excited by the promise of so many positive and rewarding opportunities ahead.”

 

 

Silo Wellness Inc. (CSE: SILO), a wellness company in the psychedelics and functional mushroom marketplaces and Ehave, Inc. (OTC: EHVVF), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today plans to collaborate on a data- study in coordination with select volunteer participants of Silo Wellness’ Jamaican psilocybin-facilitated wellness retreats.

 

The study will focus on studying transitions in and out of the altered state of consciousness caused by psychedelic molecules and offer a safe and powerful means of advancing knowledge on the neurobiology of non-ordinary conscious states. Advancing the understanding of the neurobiological underpinnings of immersive states of consciousness could ultimately help researchers find better treatment approaches for diseases such as chronic pain, depression (major and persistent), bipolar disorder, general anxiety, ADHD and Schizophrenia. Ehave’s proprietary dashboard will be used to collect and sort data from the brain mapping study.

 

Ehave will integrate Brain Scientific's NeuroCap and NeuroEEG to acquire data from participants in real time. The study with Silo Wellness will allow Ehave to deploy NeuroCap and NeuroEEG in order to capture the data around the electrophysiological changes in brain pre-, mid-, and post-psychedelic drug administration. This will allow researchers to measure the efficacy of psychedelic molecules on various mental health indications that might open new doorways for psychedelic research and development of molecules to address various mental health disorders with great precision and efficiency.

 

Ehave CEO, Ben Kaplan said, “Brain mapping reveals which areas of the brain are not working the way they should, as well as how those areas are affected by external factors." Mr. Kaplan continued, "The brain mapping process will allow us to see inside the brain to identify the effects of psilocybin molecules and its derivatives on brainwaves. From the data we receive from the brain map, a report will be generated for each patient that shows the areas affected.”

 

“Silo Wellness is delighted to collaborate on discovering innovative methods to assist in delivering the most optimal experience of wellness retreat participants through the screening of psychoactivity, which may enable us to learn even more about therapeutic dosing of psilocybin products,” commented Douglas K. Gordon, Chief Executive Officer of Silo Wellness. “Scientific approaches such as this align with our ongoing commitment to leverage technology, applications and formats, such as our patent-pending psilocybin nasal spray, to both destigmatize and transform the psychedelics landscape.”

 

The study will assimilate data of select volunteers of Jamaican psilocybin retreat participants by measuring brain activity for a duration of 15-30 minutes before the administration of psilocybin and its derivatives. The participant shall wear an EEG neurocap during the entire process of the study and for 15-30 minutes after the administration of the psilocybin and its derivatives.

 

"This study will be conducted using EEG devices to measure the brain activity before, during, and after administration of psilocybin and its derivatives. To conduct the test, we place a comfortable cap on the individual’s head. The cap contains sensors that measure brainwaves of various frequencies. This is an entirely non-invasive reading of the brain’s activity and frequency patterns," said Alfred Farrington II, Chief Information Officer of Ehave.

Dr. Manideep Gopishetty, Medical Advisor for Ehave said, “Understanding the effects psychedelics have on human brain activity and how it’s impacting the consciousness could be a key to building a more sustainable and effective treatment protocol for various mental health disorders.”

 

“This is part of Silo Wellness’s commitment to the advancing psychedelic compounds in familiar delivery modalities,” stated pharmacologist Dr. Parag Bhatt, Silo medical advisor and co-inventor of the nasal spray. “We are using this endeavor to evaluate the feasibility of an advanced tool to potentially use in a future study to prevent hyper-therapeutic dosing of psychedelics in line with our psilocybin nasal spray and other metered-dosing patent application claims.”

 

Ehave will be responsible for collecting and sorting data from the brain mapping study with its Ehave Dashboard. Ehave will also be responsible for designing the protocol for the brain mapping study, finalizing the principal investigator and medical monitor, providing the EEG equipment, as well as training the ground staff in Jamaica to handle the EEG equipment.

In addition to developing and facilitating the psilocybin-assisted wellness retreat agenda, Silo Wellness will be responsible for procuring the retreat sites for the brain mapping study to take place in Jamaica. Silo Wellness will also be responsible for facilitating the administration of psilocybin and its derivatives in natural variants.

 

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

 

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

 

Investors can trade these stocks and other ideas on our site using our  list of top stock trading apps including Robinhood , Acorn, Stash  and others.

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

The Investorideas.com podcasts are also available on iTunes ( Apple Podcasts) ,  Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio ,  Google Play Music and most audio platforms available.

 

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:

https://www.investorideas.com/About/Private_Policy.asp

 

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

 

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

 


  Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory

Friday 19 March 2021

Investorideas.com - Psychedelic Stock News: Red Light Holland (CSE: TRIP) Closes Acquisition of SR Wholesale Becoming a Leader in Distribution of Psychedelics

Investorideas.com - Psychedelic Stock News: Red Light Holland (CSE: TRIP) Closes Acquisition of SR Wholesale Becoming a Leader in Distribution of Psychedelics

#CBD #Stocks in the News: American Premium Water Corp. (OTC: $HIPH) Announces CBD Kit Launch Products for Cali Bear this Spring; @AmericanPremium

 

#CBD #Stocks in the News: American Premium Water Corp. (OTC: $HIPH) Announces CBD Kit Launch Products for Cali Bear this Spring; @AmericanPremium 

 

PLAYA VISTA, CA, March 19, 2021- Breaking CBD/Water stock news  at Investorideas.com - American Premium Water Corporation (OTC: HIPH) (the “Company”) announces its ‘Kit’ of products that will be launched as part of the Cali Bear joint venture announced last month. Cali Bear (www.calibear.life) is a performance lifestyle CBD brand that embodies sport, beach, and surf culture. The following products will be sold under the Cali Bear brand produced by the Company at launch:

 

·        16oz Nano CBD Water utilizing the Company’s proprietary nanotechnology to ensure proper hydration during competitive activity

·        2oz Nano CBD “Chill” Shot utilizing the Company’s proprietary nanotechnology designed to be used after competition to relax and recover

·        CBD infused Lip Balm which is intended to be used on and off the court to protect against chapping and blistering

·        CBD infused pain relief cream used during and after competition to relieve pain and muscle soreness

·        CBD infused gummies to be used anytime to stay “Cali Cool” anywhere and on the go

All of the products are part of the Company’s plan to create a performance lifestyle ‘Kit’ that will give consumers the tools to maintain a fun lifestyle while achieving exceptional performance.

 

Read this news, featuring HIPH in full at https://www.investorideas.com/news/2021/cannabis/03192HIPH-CBD-Cali-Bear.asp

 

Ryan Fishoff, CEO of American Premium Water, commented, “I am excited to announce the slate of products the Company will be launching as part of our Joint Venture with Cali Bear. The products selected embody performance lifestyle and are designed to support athletes on the court and appeal to non-active consumers. We have spent a lot of time developing a collection of high quality products that will fulfill a broad range of consumer needs. I believe our product ‘Kit’ provides a complete CBD solution under one brand, while appealing to diverse demographics. I am excited to begin the rollout next month with the Cali Bear Team. The athletes are great brand ambassadors and spokespeople for the brand and the products. Having an active group of athletes in international competition will be a huge asset moving forward and the Company looks forward to leveraging the content and awareness created from these events to drive sales. The full CBD Kit we have developed will help tell the story of how CBD products can be a part of consumers health and wellness routines.

 

“The Company is excited to begin selling products online and in stores. We announced a few weeks ago our first distribution partner to service over 2,000 smoke shops in the northeastern corridor. We are in discussions with other retailers and distributors. Things are moving very quickly; I look forward to the coming months as we begin the marketing campaign behind the Cali Bear CBD product launch and the rollout begins into stores. I expect this will have a positive effect on topline revenue, and I do believe that these initiatives will help increase shareholder value. I look forward to keeping investors and our community informed in the coming weeks with further developments on additional retail distribution of the Company’s CBD products,” concluded Mr. Fishoff.

 

About American Premium Water Corp.

American Premium Water (OTC: HIPH) is a diversified luxury consumer products company focused on businesses in the health and beauty and biotech sectors. The company is focused on harnessing the powers of Nano technologies paired without cannabidiol (CBD) to treat health disorders and enhance quality of life. The company’s portfolio includes the LALPINA Hydro and LALPINA CBD brands (www.lalpinahydrocbd.com),\Cali Bear (www.calibear.life) Vanexxe (www.vanexxe.com) plant + body essentials (www.plantbodyessentials.co).

 

Safe Harbor Notice

Certain statements contained herein are “forward-looking statements” (as defined in the Private Securities Litigation Reform Act of 1995). American Premium Water Corporation cautions that statements made in this news release constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates and assumptions made by management. Actual results could differ materially from current projections or implied results. American Premium Water Corporation undertakes no obligation to revise these statements following the date of this news release. Additional details of the Company's business can be found in its public disclosures as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC") EDGAR database.

 

This press release is issued on behalf of the Board of Directors of American Premium Water Corporation.

 

Investor Relations
888-983-0054
info@americanpremiumwater.com

 

Paid News -Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure : this news release featuring HIPH is a paid for news release on Investorideas.com third party by  EH Media LLC  More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

About Investorideas.com and http://www.renewableenergystocks.com/

https://www.investorideas.com/About/

 

Sign up for free stock news alerts at Investorideas.com

https://www.investorideas.com/Resources/Newsletter.asp

 

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others. 

 

 

Get more Cannabis Stock Investor Ideas - news, articles, podcasts and stock directories

 

 

Water-Stocks.com: investing ideas in water stocks

Like Water Stocks? View our Water Stocks Directory  Get News Alerts on Water Stocks

 

 

Weeding through the Winners in Cannabis Stocks (TSX: WEED) (Nasdaq: CGC) (NASDAQ: TLRY) (NASDAQ: ACB)

Weeding through the Winners in Cannabis Stocks (TSX: WEED) (Nasdaq: CGC) (NASDAQ: TLRY) (NASDAQ: ACB) : Weeding through the Winners in Canna...